Co-Located Conference AgendasNovel Formulation Strategies | QbD in Pharma Development World Congress 2017 | 
Thursday, 20 April 201708:00 | Registration | 10:00 | Inauguration | 10:10 | Welcome Address by MD, SELECTBIO | 10:15 |  | Guest of Honour Inaugural Address
P B N Prasad, Deputy Drugs Controller (India), Central Drugs Standard Control Organization, India
|
| 10:45 | Coffee Break | |
Session 1: Development Strategies for Oral Drug Delivery Formulations |
| | 11:15 | Development Strategies for Fixed Dose Combinations
Praveen Khullar, Senior Director, Sanofi Aventis Group, India
| 11:55 | Lipid-Based Drug Delivery Systems as a Solution for Oral Delivery of Challenging Compounds
Jan Vertommen, Senior Director, Capsugel, Belgium
| 12:35 | Self-Emulsifying Oral Lipid-Based Nanostructured Systems with Improved Biopharmaceutical Attributes
Bhupinder Singh Bhoop, Dean, UIPS, Panjab University, India
| 13:15 | Interactive Session | 13:40 | Lunch Break | |
Session 2: Bioequivalence Strategies for Pharmaceutical Formulations |
| | 14:40 | Is it Possible to Achieve Bio-equivalence Between an Oral Solid Immediate-release and an Analogue Enteric-coated Formulation?
Muhammad Sameer Safadi, Senior Director, Teva Pharmaceutical Industries, Ltd., Israel
| 15:20 | Critics on Bioequivalence Studies of FEW DISTINCTIVE Molecules
Shamkant Shimpi, Vice President, Centaur Pharmaceutical Limited, India
| 16:00 | Coffee Break | |
Session 3: BCS Oriented Biowaiver Strategies for Solid Oral Dosage Forms |
| | 16:20 | “Biowaiver”: An Inexpensive and Time Saving Strategy in the Formulation and Development of BCS Class I and III Oral Solid Dosage Forms
Devendra Ridhurkar, Senior Scientist, Egis Pharmaceuticals, Hungary
| 17:00 | Biowaiver Strategies for BCS-1 / BCS-3 Oral Solid Dosage Forms
Gour Mukherji, Senior Pharmaceutical Consultant, Consultancy, India
| 17:40 | End of First Day of Conference |
Friday, 21 April 2017 |
Session 4: Formulation Development Strategies of Challenging Drug Compounds |
| | 09:30 | Accelerating Formulation Development of Protein Drugs: Challenges and Opportunities
Rajiv Nayar, CEO, HTD Biosystems Inc., United States of America
| 10:10 | Solubility and Oral Bioavailability Enhancement of Pharmaceuticals: Challenges and Opportunities
Rakesh Bhasin, Head-Formulation, Biocon, India
| 10:50 | Coffee Break | |
Session 5: Formulation Development Strategies for Delivery of Biologics |
| | 11:20 | Current Technical and Regulatory Topics in Formulation and Product Development of Biologics
Satish Singh, Head, Lonza Inc, Switzerland
| 12:00 | Formulation Strategies for a Biologic to Treat Chronic Wounds
Manfred Schuster, CEO, ReMute-Bio GmbH, Austria
| |
Session 6: Formulation Strategies for Water Insoluble Drugs |
| | 12:40 | Novel Approaches to Formulate Insoluble Potent Drugs as IV Injectable with an Eye to Improve their Therapeutic Efficacy
Rambhau Devraj, Director Technical, Pulse Pharmaceuticals Pvt Ltd., India
| 13:20 | Formulation of Water Insoluble Drugs for IV Injections
Khalid Akhter Ansari, Team Lead, Novartis, India
| 14:00 | Lunch Break | |
Session 7: Academic Innovation Oral Presentations: Novel and Nanostructured Dug Delivery Systems |
| | 15:10 | Reconnoitering Scaffolds as Sustained Release Drug Delivery Carriers
Pankaj Kumar Sharma, PhD Research Scholar , DIPSAR, India
| 15:20 | Development of Supersaturated Drug Delivery System: Effect of Polymers and Implications on Supersaturation, Nucleation and Crystal Growth
Rahul Chavan, Research Scholar, NIPER Hyderabad, India
| 15:30 | Novel Lipid Nanoformulation of Artemether-Lumefantrine Combination for Oral Malaria Therapy
Rohit Pawar, PhD Research Student, Institute of Chemical Technology, India
| 15:30 | Formulation of Nano Lipid Vesicles for the Treatment of Rheumatoid Arthritis
Avril Mathias, Research Scholar, Nitte University, Mangaluru, India
| 15:40 | Lymphatic system Targeted Lipid Nanocarriers: A Promising Approach for Oral Treatment of Breast Cancer
Rashmi Prabhu, PhD (Tech) Research Student, Institute of Chemical Technology, India
| 15:50 | Lyophilized Phytosomal Nano Carriers of Rutin for Hepatoprotective Activity
Ravi GS, Research Scholar, NGSMIPS Mangalore, India
| 16:00 | Antigen Loaded Microparticles as Novel Mucosal Vaccine Delivery Systems against Airborne Pathogens
Hemali Savla, Predoctoral Research Fellow, Bombay College of Pharmacy, India
| 16:10 | NanoMicide Gel and its Delivery Device: An Alternative to Condoms for Prevention of UAI Associated HIV
Amit Mirani, Pre-Doctoral Student, Institute of Chemical Technology, India
| 16:20 | Novel Formulation of Class-II and IV Drugs to Improve Bioavailablity
Arun Radhakrishnan, PG Scholar, JSS College of Pharmacy, India
| 16:30 | Novel Anti-Oxidant Enzyme Delivery System for Prevention of Cataract
Isha Naik, , Bombay College of Pharmacy, India
| 16:40 | Oral Presentations Awards | 16:45 | Closing Remarks | 17:00 | END OF CONFERENCE |
|
Add to Calendar ▼2017-04-20 00:00:002017-04-21 00:00:00Europe/LondonNovel Formulation StrategiesNovel Formulation Strategies in HyderabadHyderabadSELECTBIOenquiries@selectbiosciences.com